Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Chugai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.

Tecentriq misses the mark in advanced ovarian cancer

Tecentriq misses the mark in advanced ovarian cancer AZ is awaiting additional decisions on Imfinzi in first-line ES-SCLC in Europe and Japan before the end of the year, and the drug is already approved for this indication

Novartis reveals full phase 3 results for Enerzair Breezhaler

Novartis reveals full phase 3 results for Enerzair Breezhaler So far, medium- and high-doses of Novartis’ drug have been approved in Japan, and high-dose Enerzair Breezhaler has also been approved in the EU and Canada, with these regulatory

Multichannel engagement and the need for greater understanding of European markets

Multichannel engagement and the need for greater understanding of European markets and Japan in the uptake of digital marketing – the volume share of digital promotional activity is just 11% compared with 21% in the US and 47% in Japan.

EMA fast-tracks review of AZ/Daiichi Sankyo’s HER2 drug

EMA fast-tracks review of AZ/Daiichi Sankyo’s HER2 drug The companies have split the cost of bringing the drug to market and will share in global profits, with the exception of Japan where Daiichi retains exclusive rights.

Harnessing the Power of Together

by Hanover Communications for Chugai. In the world of pharma everyone wants to be the ’partner of choice’. ... This was the ultimate expression of our campaign – showing how Chugai’s employees travel further and faster when they worked together.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...